The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection | Zendy

Kristine M. Erlandson | Zendy; Douglas Kitch | Zendy; C. William Wester | Zendy; Robert C. Kalayjian | Zendy; Edgar T. Overton | Zendy; José CastilloMancilla | Zendy; Susan L. Koletar | Zendy; Constance A. Benson | Zendy; Thomas Campbell | Zendy; Kevin Robertson | Zendy; Judith J. Lok | Zendy

Open Access

The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection

Author(s) -

Kristine M. Erlandson,

Douglas Kitch,

C. William Wester,

Robert C. Kalayjian,

Edgar T. Overton,

José CastilloMancilla,

Susan L. Koletar,

Constance A. Benson,

Thomas Campbell,

Kevin Robertson,

Judith J. Lok

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix645

Subject(s) - medicine , angiotensin receptor , angiotensin converting enzyme , human immunodeficiency virus (hiv) , ace inhibitor , statin , pharmacology , enzyme inhibitor , enzyme , immunology , virology , receptor , angiotensin ii , biochemistry , biology , blood pressure

Although statins, angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) are generally well tolerated, the impact of these therapies individually or in combination on the change in neurocognitive function in persons with human immunodeficiency virus infection is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research